Vanda Pharmaceuticals does not pay a cash dividend to its shareholders. As a specialized biopharmaceutical enterprise, the company retains all available capital to fund ongoing research and development programs, clinical drug pipelines, and commercial expansion efforts rather than distributing regular dividend yields.